Codes ATC:
B02BA01
EMLc
Indication
Haemorrhagic disorder due to other specified circulating anticoagulants
Code ICD11:
3B21.Y
INN
Phytomenadione
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
10 mg per mL in ampoule ;
1 mg per mL in ampoule
(EMLc)
Oral > Solid: 10 mg tablet
Oral > Solid: 10 mg tablet
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
The Subcommittee accepted that medicines affecting coagulation were essential for children and endorsed phytomenadione for inclusion in the EMLc. As phytomenadione is routinely administered to neonates, the Subcommittee decided this medicine should be included in the Core List and recommended the addition of phytomenadione injection 1 mg/ml to the EMLc.